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At an IAEA regional training course
for Asia and the Pacific, participants
are instructed on the use of com-
puters and data processing pro-
grams for reliable analysis of RIA.
Participants from 16 countries were trained in RIA methodology at an IAEA regional course held in Indonesia.
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Radioimmunoassay for human health
in developing countries
Through IAEA co-operative projects,
countries have been able to solve some basic problems
by R.D. Piyasena, P.L. Airey, R.D. Ganatra, and M. Nofal
Radioimmunoassay (RIA) is a microanalytical tech-
nique where radionuclides are used in diagnostic tests
for the measurement of minute quantities of substances,
such as hormones, vitamins, and drugs, in body fluids.
The distinct advantages of sensitivity and specificity that
the technique offers enable such measurements in small
sample volumes, and in most cases without cumbersome
extraction and purification steps. Measurement of radio-
activity, as the end point, is more accurate than chemical
estimations.
Since first introduced in the early 1960s, RIA has
gained wide acceptance as an analytical method adopted
by an increasing number of developing countries as an
appropriate technology that can be managed within the
capabilities of local infra- structures. An informed esti-
mate would be that there are, at present, in excess of 500
hospitals, university, or other laboratories in the devel-
oping world engaged in RIA on some scale.
In the developing world, RIA is used primarily for
patient management, but research activity is also in-
creasing as expertise and resources improve. The
majority of patient samples processed are in relation to
thyroid disorders, with RIAs for thyroxine (T4), tri-
iodothyronine (T3) and thyrotrophin (TSH) outnumber-
ing other procedures. However, the technique also is
used widely in the investigation of other endocrine con-
ditions and public health problems. To an encouraging
degree, some developing countries have gained the capa-
bility to perform radioisotopic microassays in areas of
clinical and research importance such as steroid receptor
quantification in breast tissue; diagnosis of bacterial and
parasitic disorders; investigation of infertility and steril-
ity; narcotic drug abuse; and organ transplantation.
Mr Piyasena is an expert in the IAEA Division of Technical Assistance
and Co-operation, and Mr Airey is the Division's co-ordinator for the
Regional Co-operative Agreement (RCA) in Asia and the Pacific.
Dr Nofal is Director of the IAEA Division of Life Sciences, and
Dr Ganatra is Head of that Division's nuclear medicine section.
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Building the infrastructure
Through its nuclear medicine (formerly medical ap-
plications) section of the Division of Life Sciences and
the Division of Technical Assistance and Co-operation,
the IAEA has served as a catalyst for RIA development
in many countries, often pioneering its introduction. Ef-
forts are mainly directed at promoting the transfer of
RIA technology to developing countries by helping
laboratories to obtain low-cost reagent supplies and to
monitor the quality of the assays.
The emphasis has been on the creation of the neces-
sary infrastructure, based on an appreciation of existing
problems and constraints, so as to enable RIA to fulfill
its potential in serving health care needs. Since RIA is
a multidisciplinary function, its introduction has to be
considered in conjunction with the availability and state
of development of other laboratory disciplines. Tem-
plate requirements are equipment, training, and reagent
supplies. Additional activities involve the maintenance
of assay quality and consistency.
Equipment. A reliable gamma scintillation counter is
essential for an RIA laboratory. The simple single-well,
manual scintillation counters initially used, even in in-
dustrialized countries, have given way to automatic
gamma and liquid scintillation spectrometers.
Costs, however, have risen in line with the equip-
ment's sophistication, and by the early 1970s, the provi-
sion of counters for RIA was not possible on a scale
commensurate with demand. To improve this situation,
the IAEA contributed to the wider use of a relatively in-
expensive gamma counter with data processing capabil-
ity that was manufactured commercially. The IAEA has
assisted in supplying this system to several RIA labora-
tories in the developing world.
Relative to increases in equipment costs for in vivo
nuclear medicine, such as gamma cameras, RIA count-
ing equipment has actually decreased in cost in recent
years. Multichannel gamma counters, when required,
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are now selected from several commercial models. Li-
quid scintillation spectrometers are only exceptionally
supplied, since an increasing number of substances, in-
cluding steroids, are now assayable using iodine-125.
Other equipment needs for basic RIA are simple. The
major item is a suitable centrifuge. Experience with RIA
centrifuges has been mixed, and some have broken down
in situations where local repair is not possible. Cog-
nizant of this, the IAEA has taken advantage of modern
developments that render RIA methods less dependent
on a centrifugation step.
Training. The IAEA attaches high priority to an ade-
quate personnel resource base for RIA projects. Trained
personnel are required in two broad areas: in the tech-
niques and methods themselves, and in the servicing,
maintenance, and repair of RIA instruments. In support
of each area, the IAEA provides expert services and
group and individual training, and organizes seminars
and symposia.
As a general rule, whenever an RIA facility is set up
anew, or upgraded, in a developing country, the services
of an expert are provided for a suitable period. The ex-
perts ensure that equipment is correctly installed and in-
troduce relevant techniques. The training of counterpart
staff is always considered important. Approximately 100
expert missions have been carried out since 1980, the
majority in the Asia and Pacific region and in Latin
America (35-40 in each region), about a dozen in
Africa, and the rest elsewhere. In many countries, RIA
has yet to be introduced. Where it has been, however,
expert missions have made achievements in the upgrad-
ing of RIA techniques and stimulating local reagent
production.
Group training activities such as interregional and
regional training courses and workshops have been ef-
fective in creating and upgrading expertise. Such
courses are now organized at a "train-the-trainers"
level, with international teaching staff. Recipients fur-
ther disseminate the knowledge gained at follow-up na-
tional or local courses overseen by the Agency. The
approach has proved fruitful and cost effective. For ex-
ample, two regional courses in the Asia and Pacific
region in 1987, each drawing attendance from 16 coun-
tries, dealt with the topics of bulk reagent methods for
RIA, quality control, and data processing. Follow-up
national courses have resulted in more than 10 times the
number of participants receiving the same training
locally.
Individual training fellowships are available under
the IAEA's technical co-operation programme. At the
academic level, they are usually made tenable in ad-
vanced laboratories. An average duration would be
3 months to a year, and the choice of host institution is
made to conform to the trainee's needs. The programme
has resulted in the majority of Member States, particu-
larly in the Asian and Latin American regions, having
key RIA laboratory personnel trained by IAEA. In addi-
tion, senior scientists have benefited from Agency-
sponsored scientific visits, of up to 8 weeks duration, for
familiarization with techniques in areas of special
interest.
Specialists and workers in developing countries have
further been kept abreast of advances in the field through
seminars on specific topics, and symposia on radioim-
munoassay and related procedures in medicine that have
been organized about every 5 years since 1970. The
meetings also provide a forum for presentation of their
own work and the opportunity for discussion with
colleagues.
Another programme, built over the past decade, is
designed to support maintenance of instruments, and
directed at promoting self-sufficiency in this area. As-
sistance extends to testing equipment, providing experts,
and conducting training activities.
Solving supply and cost problems
Costs, especially when they have to be met from
scarce foreign exchange, have been an obstacle to the
progress of RIA as well as other technologies in devel-
oping countries. The essential problem is that reagents
have had to be purchased from abroad, most often in the
form of commercial kits. Most of the kits are of good
quality and convenient to use, resulting in wide usage.
In 1987, out of more than 120 laboratories participating
in an IAEA project in the Asia and Pacific region, only
three were not totally dependent on them.
Several disadvantages, however, have begun to exert
a negative influence, particularly when clinical demand
has increased. Most laboratories in the developing world
find themselves without the financial means to purchase
RIA kits in required quantities, resulting in the RIA ser-
vice becoming highly selective. For example, assays
fairly commonly needed, such as for TSH, are either un-
available or done at unacceptably low frequency. Of the
laboratories in the Asia and Pacific region, all were
providing an RIA in 1987 for T4, most for T3, but less
than half had a TSH assay at all.
Apart from high costs, other deleterious factors to the
development of RIA include uncertain logistics of sup-
ply, customs delays, and poor storage conditions. The
net result has been a reduction in the quantity of RIA ser-
vice relative to demand and, more seriously, in quality
as well.
Many laboratories, attempting to make do with what
was on hand, have resorted to practices — for example,
neglecting duplicate sampling and disregarding standard
quality control procedures and manufacturer's protocols
— that severely compromised assay quality. Only 38 of
the 120 laboratories in the Asian region were im-
plementing quality control practices in 1987 that could
be considered as adequate. All others had no or
rudimentary quality control procedures.
Steps have been taken towards solving this problem.
Two IAEA projects in Asia and the Pacific and in Latin
America initiated in the mid-1980s are designed to deal
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Under an IAEA regional project,
laboratories were able to dramati-
cally increase their assays of
patient samples following the
introduction of a low-cost supply
scheme.
Number of patient samples assayed for thyroid hormones in 1987 in Asia and the Pacific
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primarily with the issue of improving sources of reagent
supply. Taking advantage of the availability of RIA rea-
gents in bulk at reduced costs, the initial project strategy
was to procure them from a central source and en-
courage the introduction of "in-house" assays based on
their use. Assays for thyroid-related hormones were
selected as being the most common.
Under the projects, nearly a million tubes of a com-
plete package of bulk reagents for RIA of T3 and T4,
and an immunoradiometric assay for TSH, have been
supplied from a central source to more then 150 labora-
tories in the Asia and Pacific and Latin American
regions. An intensive training programme through
regional courses, followed by others at the national level,
has been initiated to introduce the new methodology and
procedures for internal quality control and modern data
processing. Results have been closely monitored by the
IAEA.
Supply of reagents at project cost — through a system
of national co-ordinators — was done for 12-18 months.
Even within this time, the projects exerted a profound
impact on three vital areas — the introduction of new
technology, decrease in costs, and increase in work-
loads. By the end of 1987, some progress was already
evident: Every participating country in Asia and the
Pacific had acquired the TSH assay at least in its main
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centres. The same became true in Latin America early
in 1988.
The effect on costs has been dramatic. From reliable
estimates, the reagent cost of assaying a single patient
sample was reduced by a factor of about five, to less than
US $0.50, from a previous average of US $2.50. An
added advantage has been adherance to standard RIA
and internal quality control practices previously
neglected.
As the procedures became less expensive, their use
expanded to satisfy clinical demand and workloads were
at times seen to double in a single year. For example, the
total number of patient samples processed for thyroid-
related hormones in six participant laboratories in an
Asian country in 1986 was about 25 000. The figure
provided for 1987 is 55 000. In another case, the num-
ber of patient samples assayed for TSH increased from
120 in 1986 to 1000 in 1987. In a third instance, work-
loads increased over those years from 6800 to 18 000
patient samples.
Promoting self-sufficiency
These regional projects were intended to promote
self-sufficiency within each participant country to an ex-
tent scientifically and economically meaningful. Ac-
cordingly, local reagent production was systematically
stimulated following the recommendations of an expert
panel.
Regional training courses have contributed greatly to
the success of this venture. Of the 120 laboratories in
16 participating countries in the Asia and Pacific region,
only 10 (five in one country) were using a locally
produced antiserum for T4 RIA in 1987. Eight laborato-
ries (four in one country) prepared their own tracers, 11
their own standards, and 18 their own quality control
sera.
In the case of other laboratories participating in the
projects, dependence on imported materials was drasti-
cally reduced by early 1988. By then the T3 and T4
RIAs were being done using reagents that were "home
grown" (except for iodine-125 for tracer preparation) or
obtained from a production centre close at hand. The
situation in regard to reagents for the TSH immunoradi-
ometric assay is not yet satisfactory, but active steps
towards improvement are presently in train.
Participating laboratories in several countries are
now reaching self-sufficiency in reagents for T3 and T4
RIA, while others progress in this direction. In some
cases, locally produced reagents are being used, after
proper testing at internationally recognized centres, only
on a national scale. Reagents from other centres,
however, have been distributed regionally. They have
been found quite acceptable, and it is expected that the
activity would be enhanced.
Besides the scientific achievement, the main practical
advantage is decreased costs; the materials themselves
are cheaper and savings are realized in transport
charges. For example, in an Asian country, a 100-tube
assay for T4 or T3, using commercial reagents, costs the
equivalent of US $180. The same quantity, with reagents
produced locally, is offered at US $45. With the in-
creased participation of other countries in 1989, it is ex-
pected that regional "indigenization" of reagent
supplies and formalization of regional distribution
schemes would cause reagent costs to even fall under the
US $0.50 per sample achieved in 1987.
Signs of similar success are apparent .in the Latin
American project, which began a year after the Asian
one. It is now at the stage of introduction of bulk
reagent-based methods and quality control. However,
local reagent production is already at a fairly advanced
stage in some countries.
Quality and reliability assurance
Standard quality control procedures in RIA have
been, generally speaking, conspicuous by their absence
in the majority of laboratories in developing countries
for two main reasons. First was a lack of knowledge, an
appreciation of how necessary they are in RIA which,
for all its advantages, has an inherent fragility deriving
from the limited stability of the reagents. Second was the
factor of cost. Every sample devoted to quality control
meant one less patient sample.
In IAEA projects, a totally uncompromising policy
was adopted to deal with this problem. With the in-
troduction of bulk reagent-based methodology, the cost
factor as a constraint to quality control was removed, but
the essential issue of education remained. The subject
was emphasized at meetings of national co-ordinators
and regional training courses, where minimum standard
RIA practices were agreed upon. Adherance to these,
with regular reporting of results, rather than to the par-
ticular type of RIA methodology adopted, was taken as
the criterion for participation and continued IAEA sup-
port. The ideas gained wide acceptance. Although the
situation is not as yet completely satisfactory, there has
been much improvement. No laboratory has dropped out
or been excluded from projects on the grounds of inat-
tention to quality control.
Computer-assisted methods for RIA analysis. Moti-
vation towards and adoption of quality control practices
were facilitated by a parallel development that in-
troduced computer-assisted methods for the analysis of
RIA and internal quality control data. Data processing
packages have been commercially available at least since
the early 1970s. But they were expensive, and com-
puters at that time were generally beyond the means of
developing countries.
Among the first significant contributions having a
visible impact was the IAEA's development of a set of
data processing programs. They incorporate advanced
concepts but operate on an inexpensive programmable
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calculator that interfaces with a gamma counter. By the
mid-1970s, this system was being made available at a
price well below that of commercial models.
Such a data processing system that enables proper
statistical evaluation of results is a great asset to the
monitoring of assay performance. When properly used,
it also serves to promote good RIA and quality control
practices. However, though satisfactory from a technical
viewpoint, the calculator's limitations meant slow opera-
tion of data programs. In 1987-88, the IAEA upgraded
the programs to take advantage of the greater computing
power of personal computers, which are now more af-
fordable. The programs already have been used at
several training courses and distributed to about 100
RIA laboratories. About 50 laboratories also have been
supplied with computers recently under various IAEA
projects. Currently, computers and data processing sys-
tems are available in almost all countries in Asia and the
Pacific and in Latin America, at least at major centres,
and are being enthusiastically used.
RIA for research in developing countries
In common with other medical disciplines, RIA in
developing countries has overwhelmingly served patient
care. Where lack of equipment, trained manpower, and
reagent supplies have been a constraint to fulfilment of
this function, the impediment to research has been even
greater. Direct support for research by IAEA is most
commonly through co-ordinated research programmes
confined to a few participants, and through research
grants to individual institutions.
The growing use of RIA techniques at reduced cost
has increased research possibilities through various
mechanisms. Research into thyroid-related disorders has
been stimulated in many countries, particularly where
skills were available but means were few. As cases in
point, several articles have been published recently in
prestigious journals by authors from laboratories in the
Asian region where bulk reagent methodology obtained
under IAEA projects is being employed. Independent
and locally supported research into iodine deficiency
disorders has been initiated in some countries. About 10
regional laboratories in Asia have been carrying out a
clinical trial of a strategy for in vitro thyroid function
testing since 1988.
Future plans and developments
Experience over the past 3 years has shown that an in-
tegrated approach to projects on a regional basis is suc-
cessful and cost-effective where countries share
common problems. Moreover, the projects were able to
bring together a team of well-trained and motivated wor-
kers. The spirit that now exists can be fostered and ex-
ploited in several areas, most notably in sharing reagent
supplies.
In the Asia and Pacific region, an external quality as-
sessment scheme for thyroid-related hormones will be
established in 1989 at a regional level, with perhaps an
interregional component as well. A training course will
deal with the optimization of local reagent production
activities, and formalize the regional reagent distribution
scheme initiated in 1988. The RIA data processing pro-
grams are being completed in an "on-line" version. A
major innovation will be the introduction of RIAs that do
not include a centrifugation step (such as magnetizable
particle-linked systems) for laboratories lacking such an
instrument. The local availability of the required
materials, a recent development in itself, makes this an
immediate realistic activity.
Thyroid-related hormones have been chosen for the
regional projects as a first example. There has been a
strong demand from national co-ordinators that similar
regional projects be organized in areas of other major
health problems. The present infrastructure, including
trained workers in adequately equipped laboratories
already co-operating with each other, can thus be used
to the best effect. Specific proposals are under
consideration.
Overall, RIA is expected to have a long life span in
developing countries requiring an appropriate and prac-
tical technology for health care and research. Tech-
niques are becoming simpler and of more universal
applicability, so horizons of RIA could broaden. The
IAEA's promotion of RIA, with its sound track record
in developing countries, will be needed through the
challenging times ahead.
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